Here's a news article based on the latest developments concerning the mentioned stocks:

Indian Stock Market Updates: Hyundai India, Vedanta, Adani Power, Tata Motors, and Aurobindo Pharma in Focus

The Indian stock market has seen a flurry of activity with several key players making headlines. Shares of Hyundai Motor India, Vedanta, Adani Power, Tata Motors, and Aurobindo Pharma are expected to be closely watched by investors following recent news and developments.

Hyundai Motor India

Hyundai Motor India has announced that it will be passing on the benefits of the recent GST (Goods and Services Tax) rate cuts to its customers by reducing the prices of its passenger vehicle models. The price cuts will range from ₹60,640 on the Verna to ₹2.4 lakh on the premium SUV Tucson and will be applicable from September 22, 2025. This move is expected to make personal mobility more affordable and accessible to millions of customers. However, the company reported a 4.23% year-on-year decline in total sales for August 2025, with 60,501 units sold compared to 63,175 units in the same month last year. Despite the sales dip, Hyundai's shares closed up 2.41% on Friday.

Vedanta

Vedanta Group has emerged as the highest bidder for Jaiprakash Associates, a debt-laden company with interests spanning real estate, cement, power, hotels, and roads. Vedanta offered ₹17,000 crore, with a net present value of ₹12,505 crore, in an open challenge round. The offer includes an upfront payment of ₹4,000 crore post approval by NCLT (National Company Law Tribunal), with the remaining amount to be paid over the next 5-6 years. Vedanta's winning bid surpassed that of the Adani Group. Sources indicate that Vedanta aims to leverage JAL's assets through its experience in metals, mining, and power, and also tap into the potential of JAL's limestone and coal mines. Shares of Vedanta settled at ₹445.80 apiece on the National Stock Exchange on Friday, surging 2.32%. The company also declared a second interim dividend of ₹16 per share for FY26.

Adani Power

Adani Power's shareholders have approved a 1:5 stock split. The board's decision, which was approved on September 5, 2025, follows the company's financial results for Q2 2025. The company has fixed September 22 as the record date for the sub-division of equity shares. Each equity share of ₹10 will be sub-divided into five fully paid-up equity shares of the face value of ₹2 each. Post-split, the number of equity shares will increase from 2,480 crore to 12,400 crore. Adani Power has also announced a significant expansion with Druk Green Power Corp Ltd (DGPC), Bhutan's state-owned generation utility, to develop a 570 MW hydroelectric project. However, Adani Power share price declined over 1% during the session on Friday, September 5.

Tata Motors

Tata Motors has announced it will fully pass on the GST rate cut on passenger vehicles to buyers from September 22, 2025. Prices of its cars and SUVs will drop by ₹65,000 to ₹1.55 lakh across segments ahead of the festive season. Furthermore, the company will pass on the full benefit of the GST reduction on its entire commercial vehicle range to customers, effective September 22, 2025. The prices of the CV range would decrease in the range of ₹30,000 to ₹4.65 lakh. Tata Motors' total wholesales rose 2% YoY to 73,178 units last month. Tata Motors is trading 0.63% upper at Rs 691.85 as compared to its last closing price on Friday, September 5.

Aurobindo Pharma

Aurobindo Pharma's subsidiary, Apitoria Pharma Private Limited, has received an Establishment Inspection Report (EIR) with a Voluntary Action Indicated (VAI) classification from the US FDA for its Unit-2 API manufacturing facility in Telangana. The inspection was conducted from September 23 to 27. This follows a previous inspection at Aurobindo's Unit-XII facility, which resulted in eight procedural observations. Additionally, the US FDA concluded inspection at company's manufacturing unit at Bachupally, Telangana with 8 observations. Aurobindo Pharma expects its China plant to break even at the EBITDA level this year. Aurobindo Pharma Ltd. stock last traded price is 1,044.10, moved up by 0.79% from its previous close of Rs 1,036.00 on Friday, September 5.